A new strategic research and development (R&D) alliance was announced on May 17, 2021 between BlueRock Therapeutics LP, FUJIFILM Cellular Dynamics Inc (FCDI) and Opsis Therapeutics LLC to develop new cell therapies…
Read More
Fighting Blindness Canada, partnering with the Canadian Council of the Blind and key partners, the Canadian Association of Optometrists and the Canadian Ophthalmological Society, commissioned new research, The Cost of Vision loss…
Read More
Increased wait times, postponed surgeries and postponed eye injections among the impacts the pandemic has had on eye care in the province. The COVID-19 pandemic has had dire consequences for Ontario patients…
Read More
Fighting Blindness Canada (FBC) is pleased to announce a new award to support research by Dr. Arlene Drack (University of Iowa) to develop a new gene therapy treatment for retinal degeneration caused…
Read More
Charles Bonnet Syndrome (CBS) is a condition where a person with vision loss sees things that aren’t there (visual hallucinations). CBS is caused by the brain adjusting to significant vision loss and…
Read More
This World Glaucoma Awareness Week we’re helping raise awareness by sharing valuable information about glaucoma and answering common questions surrounding symptoms, risk, and prevention. Keep reading to learn from ophthalmologist and glaucoma…
Read MoreJoin the Fight!
Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our e-newsletter that lands in inboxes the beginning of each month.
